These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

4858 related items for PubMed ID: 3237611

  • 1. Demonstration of B700 cross-reactive antigens on human and other animal melanomas.
    Gersten DM, Hearing VJ.
    Pigment Cell Res; 1988; 1(6):434-8. PubMed ID: 3237611
    [Abstract] [Full Text] [Related]

  • 2. Serological characterization of a shared melanoma-associated antigen of mouse melanomas: relationship to the B700 glycoprotein.
    DeLeo AB, Hearing VJ, Vieira WD, Law LW.
    Melanoma Res; 1991; 1(2):133-40. PubMed ID: 1668533
    [Abstract] [Full Text] [Related]

  • 3. The intracellular association of B700 and B50 murine melanoma antigens and their role in tumor rejection.
    Gersten DM, Williams LJ, Moody D, Montague PM, Law LW, Hearing VJ.
    Int J Cancer; 1989 Mar 15; 43(3):497-500. PubMed ID: 2925280
    [Abstract] [Full Text] [Related]

  • 4. Studies on the relationship of the B700 and B50 murine melanoma antigens.
    Hearing VJ, Marchalonis JJ, Gersten DM.
    J Natl Cancer Inst; 1986 Sep 15; 77(3):763-6. PubMed ID: 3462414
    [Abstract] [Full Text] [Related]

  • 5. Murine melanoma-specific tumor rejection activity elicited by a purified, melanoma-associated antigen.
    Hearing VJ, Gersten DM, Montague PM, Vieira WD, Galetto G, Law LW.
    J Immunol; 1986 Jul 01; 137(1):379-84. PubMed ID: 3711669
    [Abstract] [Full Text] [Related]

  • 6. Cross-reactivity between murine melanoma antigen B700 and a human melanoma-associated antigen (M-66) recognized by autologous antibody: evidence suggesting shared epitopes.
    Toporowicz A, Gersten DM, Hearing VJ, Brown WE, Vlock DR.
    Biochim Biophys Acta; 1993 Aug 04; 1182(1):51-6. PubMed ID: 7688577
    [Abstract] [Full Text] [Related]

  • 7. A unique tumor rejection antigen from the S91 murine malignant melanoma.
    Law LW, Vieira WD, Kameyama K, Hearing VJ.
    Cancer Res; 1987 Nov 15; 47(22):5841-5. PubMed ID: 3664485
    [Abstract] [Full Text] [Related]

  • 8. Production of monoclonal antibodies against the B700 murine melanoma antigen and their antimetastatic properties.
    Gersten DM, Moody D, Vieira WD, Law LW, Hearing VJ.
    Biochim Biophys Acta; 1992 Feb 14; 1138(2):109-14. PubMed ID: 1540656
    [Abstract] [Full Text] [Related]

  • 9. Immunostaining of human melanomas by a monoclonal antibody to B700 mouse melanoma antigen.
    Xu X, Azumi N, Skelton HG, Hearing VJ, Gersten DM.
    Eur J Cancer; 1996 Jan 14; 32A(1):168-73. PubMed ID: 8695227
    [Abstract] [Full Text] [Related]

  • 10. Melanoma antigens as modified normal gene sequences.
    Bitterman P, Hearing VJ, Gersten DM.
    Life Sci; 1987 Jun 08; 40(23):2207-13. PubMed ID: 3295444
    [Abstract] [Full Text] [Related]

  • 11. Serologic demonstration of the albuminoid nature of the B700 murine melanoma antigen.
    Gersten DM, Bijwaard KE, Walden TL, Hearing VJ.
    Proc Soc Exp Biol Med; 1991 Jul 08; 197(3):310-6. PubMed ID: 1712493
    [Abstract] [Full Text] [Related]

  • 12. Temporal synthesis and presentation of antigens by cultured B16 melanoma cells.
    Gersten DM, Phillips TM, Hearing VJ.
    Pigment Cell Res; 1987 Jul 08; 1(2):118-23. PubMed ID: 3333835
    [Abstract] [Full Text] [Related]

  • 13. Studies on the expression and immunogenicity of the B50 melanoma antigen and its relationship with calreticulin.
    Bijwaard K, Hearing VJ, Sontheimer R, Lieu TS, Vieira WD, Gersten DM.
    Melanoma Res; 1995 Oct 08; 5(5):327-36. PubMed ID: 8541723
    [Abstract] [Full Text] [Related]

  • 14. Monoclonal antibody production to a B16 melanoma associated antigen.
    Tomita Y, Montague PM, Hearing VJ.
    Int J Cancer; 1985 Apr 15; 35(4):543-7. PubMed ID: 3886561
    [Abstract] [Full Text] [Related]

  • 15. Comparative analysis of immunocritical melanoma markers in the mouse melanoma cell lines B16, K1735 and S91-M3.
    Peter I, Mezzacasa A, LeDonne P, Dummer R, Hemmi S.
    Melanoma Res; 2001 Feb 15; 11(1):21-30. PubMed ID: 11254112
    [Abstract] [Full Text] [Related]

  • 16. Malignant melanoma: cross-reacting (common) tumor rejection antigens.
    Hearing VJ, Vieira WD, Law LW.
    Int J Cancer; 1985 Mar 15; 35(3):403-9. PubMed ID: 2579039
    [Abstract] [Full Text] [Related]

  • 17. Homology of the B50 murine melanoma antigen to the Ro/SS-A antigen of human systemic lupus erythematosus and to calcium-binding proteins.
    Gersten DM, Bijwaard KE, Law LW, Hearing VJ.
    Biochim Biophys Acta; 1990 Nov 14; 1096(1):20-5. PubMed ID: 2268681
    [Abstract] [Full Text] [Related]

  • 18. B700, an albumin-like melanoma-specific antigen, is a vitamin D binding protein.
    Farzaneh NK, Walden TL, Hearing VJ, Gersten DM.
    Eur J Cancer; 1991 Nov 14; 27(9):1158-62. PubMed ID: 1835629
    [Abstract] [Full Text] [Related]

  • 19. Expression of tumor antigen correlated with metastatic potential of Lewis lung carcinoma and B16 melanoma clones in mice.
    Falcioni R, Kennel SJ, Giacomini P, Zupi G, Sacchi A.
    Cancer Res; 1986 Nov 14; 46(11):5772-8. PubMed ID: 3756921
    [Abstract] [Full Text] [Related]

  • 20. Generation of cytotoxic antibodies to the B16 murine melanoma using a formalinized vaccine.
    Shrayer D, Kouttab N, Maizel A, Wanebo H, Hearing VJ, Gersten DM.
    Int J Cancer; 1993 Feb 20; 53(4):696-702. PubMed ID: 8436442
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 243.